Ramya attracts thousands in Mangaluru; miscreants pelt stones

Bengaluru, Mar 13: Senior IPS officer KSR Charan Reddy, who was the Additional Director General of Police in Criminal Investigation Department, Karnataka passed away in Bengaluru on Friday after prolonged illness. 

He was reportedly battling cancer for at least three years now and had suffered multiple recurs after treatment. 

"Shri Charan Reddy, IPS, ADGP, Karnataka State, passed away this morning, after a prolonged illness. He was one of our finest officers. Always stood tall and held his head high!! May his soul rest in peace," Retired IPS officer and former Director General of Police (Fire Services) MN Reddi tweeted. 

IPS officer Charan Reddy was heading the Special Investigation Team of the Lokayukta when he arrested Vijayanagara MLA Anand Singh in 2015 for illegally transporting iron ore out of Ballari. The illegal mining scam had rocked the former BJP government in 2011.

Karnataka Chief Minister BS Yediyurappa condoled his death and said that he was an honest officer in the state. "Charan Reddy was a dedicated and honest officer. I pray that his soul rests in peace. I pray that god gives his family the strength to go through such a turbulent time after his departure," BS Yediyurappa tweeted. 

A 1993-batch IPS officer, Charan Reddy KSR is originally from Chittoor and has served under various departments of the state's police force. He was serving as the Inspector General of Police in Belagavi division in 2013, when he was transferred to Bengaluru as the IGP (Training). In 2014, he was posted as the IGP of the SIT probing the illegal mining scam in which former Tourism Minister Gali Janardhana Reddy is also allegedly involved.

He was transferred out of the SIT in Lokayukta in 2016 and posted as Additional Commissioner of Police (law and order) in Bengaluru. He served as the ADGP of Crime in Mangaluru in 2018 and was later appointed as the Additional Director General of Police (training) the same year. In 2019, he was transferred and appointed as the ADGP of CID.

Bengaluru, Jun 3: Kempegowda International Airport in Bengaluru on Tuesday intensified preventive measures to contain the spread of COVID-19 in a bid to make air-travel contactless.

The airport has introduced contact-less self-check-in kiosks, non-intrusive thermal cameras, self bag drop facility and other features.

Bangalore International Airport Limited (BIAL) had earlier said that it will ensure that the taxis are sanitised and the drivers are screened before every trip to eliminate all chances of infection.

"Drivers have been instructed to maintain a safe distance. They will be encouraged to use hand sanitiser and face masks to make the car a safe space. Able-bodied passengers are advised to load their luggage into the car without the driver's assistance. For elderly citizens and passengers with reduced mobility, drivers will assist while following hygiene measures," BIAL statement had said.

The masks have been made mandatory for both drivers as well as passengers.

Karnataka on Monday reported 187 new cases of coronavirus, with which the State's total COVID-19 count has surged to 3,408.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.